Post-translational modifications (PTMs) of both tau and α-synuclein play crucial roles in synucleinopathies and tauopathies, potentially influencing their aggregation and contributing to the neurodegenerative pathogenesis [15, 16]. The gene discussed is MAPT; the disease is synucleinopathy.